Cempra Pharmaceuticals, Inc. Names David Moore As Chief Commercial Officer To Manage Commercial Development And Launch Of Solithromycin And Taksta™  
1/7/2014 9:39:52 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHAPEL HILL, N.C., Jan. 7, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced the appointment of David Moore as executive vice president and chief commercial officer (CCO) to manage the commercial development and launch of solithromycin and Taksta(TM).

Help employers find you! Check out all the jobs and post your resume.